Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2025)

Century Therapeutics (IPSC) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $507000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 61.62% to $507000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.0 million, a N/A change, with the full-year FY2024 number at $4.8 million, up 20.78% from a year prior.
  • Amortizatization of Intangibles was $507000.0 for Q3 2025 at Century Therapeutics, down from $647000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q2 2024 to a low of $507000.0 in Q3 2025.